Cargando…

Malignant Evaluation and Clinical Prognostic Values of m6A RNA Methylation Regulators in Glioblastoma

N6-methyladenosine (m6A) RNA methylation, the most common form of mRNA modification and regulated by the m6A RNA methylation regulators (“writers,” “erasers,” and “readers”), has been reported to be associated with the progression of the malignant tumor. However, its role in glioblastoma (GBM) has b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Jianyang, Hou, Kuiyuan, Mi, Shan, Ji, Hang, Ma, Shuai, Ba, Yixu, Hu, Shaoshan, Xie, Rui, Chen, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075451/ https://www.ncbi.nlm.nih.gov/pubmed/32211315 http://dx.doi.org/10.3389/fonc.2020.00208

Ejemplares similares

Identification of Prognostic Model and Biomarkers for Cancer Stem Cell Characteristics in Glioblastoma by Network Analysis of Multi-Omics Data and Stemness Indices
por: Du, Jianyang, et al.
Publicado: (2020)

Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy
por: Ji, Hang, et al.
Publicado: (2021)

Multiomics Data Analysis and Identification of Immune-Related Prognostic Signatures With Potential Implications in Prognosis and Immune Checkpoint Blockade Therapy of Glioblastoma
por: Ma, Shuai, et al.
Publicado: (2022)

Integrated analysis of genome-wide DNA methylation and cancer-associated fibroblasts identified prognostic biomarkers and immune checkpoint blockade in lower grade gliomas
por: Dong, Jiawei, et al.
Publicado: (2023)

Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development
por: Ma, Shuai, et al.
Publicado: (2021)

Prognostic Value and Biological Function of Galectins in Malignant Glioma
por: Zhu, Hongtao, et al.
Publicado: (2022)

Identification of Implications of Angiogenesis and m6A Modification on Immunosuppression and Therapeutic Sensitivity in Low-Grade Glioma by Network Computational Analysis of Subtypes and Signatures
por: Li, Bo, et al.
Publicado: (2022)

The Prognostic Value of NANO Scale Assessment in IDH-Wild-Type Glioblastoma Patients
por: Kasper, Johannes, et al.
Publicado: (2021)

5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas
por: Zhang, Jiheng, et al.
Publicado: (2022)

m(6)A RNA Methylation Regulators Contribute to Malignant Progression and Have Clinical Prognostic Impact in Gastric Cancer
por: Su, Yunshu, et al.
Publicado: (2019)

Assessment of Prognostic Value of Cystic Features in Glioblastoma Relative to Sex and Treatment With Standard-of-Care
por: Curtin, Lee, et al.
Publicado: (2020)

Genetic Alterations and Transcriptional Expression of m(6)A RNA Methylation Regulators Drive a Malignant Phenotype and Have Clinical Prognostic Impact in Hepatocellular Carcinoma
por: Zhu, Gui-Qi, et al.
Publicado: (2020)

Prognostic value of 12 m7G methylation-related miRNA markers and their correlation with immune infiltration in breast cancer
por: Zhang, Wenchuan, et al.
Publicado: (2022)

Prognostic value of prognostic nutritional index score and controlling nutritional status score in patients with glioblastoma: A comprehensive meta-analysis
por: Peng, Jie, et al.
Publicado: (2023)

Novel macrophage-related gene prognostic index for glioblastoma associated with M2 macrophages and T cell dysfunction
por: Ji, Hang, et al.
Publicado: (2022)

The Value of Tumor Treating Fields in Glioblastoma
por: Zhang, Chaochao, et al.
Publicado: (2020)

M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme
por: Wang, Li-chong, et al.
Publicado: (2020)

Rapid progression of subcutaneous glioblastoma: A case report and literature review
por: Wang, Fang, et al.
Publicado: (2023)

Pituitary adenoma secondary to primary hypothyroidism: Two case reports
por: Du, Jianyang, et al.
Publicado: (2020)

Dysregulation of the Immune Microenvironment Contributes to Malignant Progression and Has Prognostic Value in Bladder Cancer
por: Zheng, Zongtai, et al.
Publicado: (2020)

The prognostic value of fibrinogen to albumin ratio in malignant tumor patients: A meta-analysis
por: Li, Baibei, et al.
Publicado: (2022)

Therapeutic Prospects of mRNA-Based Gene Therapy for Glioblastoma
por: Tang, Xiangjun, et al.
Publicado: (2019)

Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma
por: Zhou, Xuanchen, et al.
Publicado: (2020)

Construction of m6A-Related lncRNA Prognostic Signature Model and Immunomodulatory Effect in Glioblastoma Multiforme
por: Xie, Pan, et al.
Publicado: (2022)

Prognostic Value of the Neo-Immunoscore in Renal Cell Carcinoma
por: Guo, Congfang, et al.
Publicado: (2019)

Gene Signatures and Prognostic Values of m(6)A Genes in Nasopharyngeal Carcinoma
por: Lu, Shanshan, et al.
Publicado: (2020)

Human Cerebrospinal Fluid Modulates Pathways Promoting Glioblastoma Malignancy
por: Carrano, Anna, et al.
Publicado: (2021)

A Hematological-Related Prognostic Scoring System for Patients With Newly Diagnosed Glioblastoma
por: Zhao, Chao, et al.
Publicado: (2020)

Preoperative Prediction Nomogram Based on Integrated Profiling for Glioblastoma Multiforme in Glioma Patients
por: Wu, Wei, et al.
Publicado: (2020)

Identification of EMT-Related Genes and Prognostic Signature With Significant Implications on Biological Properties and Oncology Treatment of Lower Grade Gliomas
por: Wu, Jiasheng, et al.
Publicado: (2022)

The Effect of m6A Methylation Regulatory Factors on the Malignant Progression and Clinical Prognosis of Hepatocellular Carcinoma
por: Zhao, Zhongwei, et al.
Publicado: (2020)

Prognostic value of receptor tyrosine kinases in malignant melanoma patients: A systematic review and meta-analysis of immunohistochemistry
por: Lei, Xuan, et al.
Publicado: (2022)

Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma
por: Tirrò, Elena, et al.
Publicado: (2021)

SETMAR Shorter Isoform: A New Prognostic Factor in Glioblastoma
por: Lié, Oriane, et al.
Publicado: (2022)

LASSO-based screening for potential prognostic biomarkers associated with glioblastoma
por: Tian, Yin, et al.
Publicado: (2023)

Prognostic Value of Programmed Cell Death Ligand-1 Expression in Nasopharyngeal Carcinoma: A Meta-Analysis of 1,315 Patients
por: Liu, Xiaofeng, et al.
Publicado: (2019)

Prognostic Value of Vimentin Is Associated With Immunosuppression in Metastatic Renal Cell Carcinoma
por: Yao, Jia xi, et al.
Publicado: (2020)

Preoperative Naples prognostic score is a reliable prognostic indicator for newly diagnosed glioblastoma patients
por: Li, Junhong, et al.
Publicado: (2022)

Prognostic and Predictive Value of m6A “Eraser” Related Gene Signature in Gastric Cancer
por: Xu, Xin, et al.
Publicado: (2021)

Effect of m(6)A RNA Methylation Regulators on Malignant Progression and Prognosis in Renal Clear Cell Carcinoma
por: Wang, Jiawu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_29s147v101o9obj6gdr841n3nr